key: cord-0975224-b8knqysh
authors: Hu, Shuaishuai
title: Comment on “Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19”
date: 2020-04-24
journal: J Med Virol
DOI: 10.1002/jmv.25937
sha: 949c177ad397168bab528403314d333f1e25a647
doc_id: 975224
cord_uid: b8knqysh

I read with this informative review article by Cheng et al. “ Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19”. I would like to talk about the role of ACE2 in endothelial cell function. Besides, I would like to mention that COVID‐19 patients might benefit from ACEI/ARBs concerning improving endothelial dysfunction in COVID‐19. This article is protected by copyright. All rights reserved.

Dear editor, I read with this informative review article by Cheng et al. " Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19" 1 .

They mentioned that the protective effect of angiotensin-converting enzyme 2 (ACE2) on heart and lung. However, it is still under discussion whether the COVID-19 patients could be beneficial from a high level of ACE2 expression. Furthermore, it is still unclear whether hypertension linked COVD-19 patients should continue to take ACEI/ ARBs. Here, I would like to talk about the role of ACE2 concerning endothelial cell function. Besides, I would like to mention that COVID-19 patients might benefit from ACEI/ARBs concerning improving endothelial dysfunction in COVID-19.

It is well studied that SARS-CoV-2 infects the host by binding ACE2 receptor 1 , which is widely expressed in endothelial cells 1 . The evidence was further shown that endothelial cells were infected by the virus leading to endothelial dysfunction in COVID-19 patients 2 . Therefore, improving endothelial function may open a new therapeutic avenue in COVID-19 patients.

It is well established that Angiotensin II (ANG II) is one of the main effectors of endothelial dysfunction and is mainly regulated by the renin-angiotensin system (RAS) 3 ACE2 played as a negative regulator of the RAS, which promotes the degradation of ANGII and maintains endothelium homeostasis 1 . Several studies have shown overexpression of ACE2 could improve endothelial repair and regeneration 3,4 . In addition, virus-induced ACE2 abscission and a decrease in the level of ACE2 contribute to developing pulmonary edema and acute respiratory distress syndrome 5 . This article is protected by copyright. All rights reserved.

Taken together, above studies indicate that the approaches to increase ACE2 may provide effective therapy for improving endothelial dysfunction in COVID-19.

Regarding whether COVID-19 patients with hypertension should continue take ACEI /ARBs. On the one hand, studies have shown ACEI/ARBs increase ACE2 level 6 , which protects heart and lung functions 1 . Furthermore, animal and human studies confirm that the beneficial effects of ACEI in reversing endothelial dysfunction 7 . On the other hand, regarding the concerning that the high level of ACE2 expression might facilitate infection with COVID-19, there is no direct evidence shown that ACE2 level is positively correlated with the infection risk. Several studies reported that COVID-19 related mortality was higher in men and the elderly than women and the young, but the level of ACE2 was shown oppositely 6,8 . Moreover, Zhang et al. have reported that ACEI/ARB was associated with lower mortality in COVID-19 patients with hypertension 9 . In conclusion, COVID-19 patients with hypertension may benefit from ACEI/ARBs by increasing ACE2 and improving endothelial functions. Besides, other anti-hypertension drugs, such as amiloride, might be used to treat hypertension-linked COVID, which has shown improved endothelial functions 6,10 .

Organ-protective effect of angiotensinconverting enzyme 2 and its effect on the prognosis of COVID-19

Endothelial cell infection and endotheliitis in COVID-19

Amiloride improves endothelial function and reduces vascular stiffness in female mice fed a Western diet

This article is protected by copyright. All rights reserved